Lupus Landmark Study: A Prospective Registry and Biorepository

Lupus Landmark Study: A Prospective Registry and Biorepository

This is a multicenter registry and biorepository conducted in the United States (US) and Canada. The registry will enroll over 3500 individuals with SLE over the course of five years into one of following four cohorts:

New Onset: individuals with a new diagnosis of SLE
Active Lupus Nephritis: individuals with a recent diagnosis of LN
Extra-Renal Lupus Flare: individuals who have experienced a recent flare
Prevalent Cases: individuals with lupus who do not meet the criteria for one of the other cohorts

The registry data will include but is not limited to: patient demographics, medical history, clinician-reported outcomes (ClinROs), patient-reported outcomes (PROs), social history and determinants of health, and environmental exposures. Participants will also be asked to allow access to their medical records.
Biological samples, including whole blood, urine, saliva, stool and tissue will be collected throughout the study. These biospecimens will be used for a broad range of analyses, including genetics, genomics, proteomics, biomarker discovery and microbiome profiling.

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 9, 2023Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | | Drug Trials Near Me | US National Library of Medicine